Royce TJ - Search Results

1

Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study.

Stokes WA, Hendrix LH, Royce TJ, Allen IM, Godley PA, Wang AZ, Chen RC. Stokes WA, et al. Among authors: royce tj. Cancer. 2013 Jul 1;119(13):2486-93. doi: 10.1002/cncr.27975. Epub 2013 May 28. Cancer. 2013. PMID: 23716470 Free article.

2

Impact of age and comorbidity on treatment and outcomes in elderly cancer patients.

Chen RC, Royce TJ, Extermann M, Reeve BB. Chen RC, et al. Among authors: royce tj. Semin Radiat Oncol. 2012 Oct;22(4):265-71. doi: 10.1016/j.semradonc.2012.05.002. Semin Radiat Oncol. 2012. PMID: 22985808 Review.

3

Cancer screening rates in individuals with different life expectancies.

Royce TJ, Hendrix LH, Stokes WA, Allen IM, Chen RC. Royce TJ, et al. JAMA Intern Med. 2014 Oct;174(10):1558-65. doi: 10.1001/jamainternmed.2014.3895. JAMA Intern Med. 2014. PMID: 25133746

4

Stereotactic body radiation therapy for high-riskprostate cancer: Not ready.

Royce TJ, Chen RC. Royce TJ, et al. Pract Radiat Oncol. 2018 May-Jun;8(3):203-205. doi: 10.1016/j.prro.2018.01.002. Epub 2018 Jan 12. Pract Radiat Oncol. 2018. PMID: 29452876 Review. No abstract available.

5

Trimodality therapy for HPV-positive oropharyngeal cancer: A population-based study: Trimodality therapy for HPV+ OPC.

Sanford NN, Hwang WL, Pike LRG, Lam AC, Royce TJ, Mahal BA. Sanford NN, et al. Among authors: royce tj. Oral Oncol. 2019 Nov;98:28-34. doi: 10.1016/j.oraloncology.2019.09.009. Epub 2019 Sep 16. Oral Oncol. 2019. PMID: 31536843 Free PMC article.

6

Analysis of Price Transparency via National Cancer Institute-Designated Cancer Centers' Chargemasters for Prostate Cancer Radiation Therapy.

Agarwal A, Dayal A, Kircher SM, Chen RC, Royce TJ. Agarwal A, et al. Among authors: royce tj. JAMA Oncol. 2020 Mar 1;6(3):409-412. doi: 10.1001/jamaoncol.2019.5690. JAMA Oncol. 2020. PMID: 31944219 Free PMC article.

7

Outcomes of HPV-Associated Squamous Cell Carcinoma of the Head and Neck: Impact of Race and Socioeconomic Status.

Pike LRG, Royce TJ, Mahal AR, Kim DW, Hwang WL, Mahal BA, Sanford NN. Pike LRG, et al. Among authors: royce tj. J Natl Compr Canc Netw. 2020 Feb;18(2):177-184. doi: 10.6004/jnccn.2019.7356. J Natl Compr Canc Netw. 2020. PMID: 32023531 Free PMC article.

8

Low Utilization of Androgen Deprivation Therapy Among Men Receiving Stereotactic Body Radiotherapy for Localized Prostate Cancer in the United States.

Royce TJ, Switchenko JM, Zhang C, Spratt DE, Chen RC, Jani AB, Patel SA. Royce TJ, et al. Eur Urol Oncol. 2021 Apr;4(2):337-338. doi: 10.1016/j.euo.2020.06.006. Epub 2020 Jul 2. Eur Urol Oncol. 2021. PMID: 32624420 Free PMC article. No abstract available.

9

Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.

Royce TJ, Mavroidis P, Wang K, Falchook AD, Sheets NC, Fuller DB, Collins SP, El Naqa I, Song DY, Ding GX, Nahum AE, Jackson A, Grimm J, Yorke E, Chen RC. Royce TJ, et al. Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):227-236. doi: 10.1016/j.ijrobp.2020.08.014. Epub 2020 Sep 6. Int J Radiat Oncol Biol Phys. 2021. PMID: 32900561 Free PMC article.

10

Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancer.

Patel SA, Switchenko JM, Fischer-Valuck B, Zhang C, Rose BS, Chen RC, Jani AB, Royce TJ. Patel SA, et al. Among authors: royce tj. Radiat Oncol. 2020 Sep 15;15(1):217. doi: 10.1186/s13014-020-01658-5. Radiat Oncol. 2020. PMID: 32933541 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page